MedTrace Logo

Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments, Using Multiomics

NCT05736029 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 350

Last updated 2023-02-21

No results posted yet for this study

Summary

The goal of this exploratory study is understand the mechanisms of response to immunotherapy in Non-Small Cell Lung Cancer patients.

The investigators are going to search for correlation between specific biological features and response to immunotherapy, and to use those associations for developing an algorithm enabling to identify patients that could benefit from the immune check inhibitor based anti cancer treatment.

Patients will provide biological samples before and during their treatment, and clinical data will be collected.

Conditions

  • Non Small Cell Lung Cancer
  • Healthy

Interventions

OTHER

blood, stool and tissue samples collection

blood, stool and tissue samples collection before and during the treatment, as applicable

Sponsors & Collaborators

  • OncoHost Ltd.

    lead INDUSTRY

Principal Investigators

  • Ronan J Kelly, MD MBA · Chief of Oncology Baylor Scott & White Health System

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-11-07
Primary Completion
2028-01-01
Completion
2028-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05736029 on ClinicalTrials.gov